Pacira BioSciences (PCRX) News Today → Write this ticker symbol down… (From StocksToTrade) (Ad) Free PCRX Stock Alerts $28.57 -0.55 (-1.89%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 11:55 AM | marketbeat.comRubric Capital Management LP Buys 31,685 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Rubric Capital Management LP lifted its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 6.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 491,322 shares of the company's stock after acquiring an additional 31,685June 8 at 11:24 PM | marketbeat.comDoma Perpetual Capital Management LLC Takes Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Doma Perpetual Capital Management LLC bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 186,321 shares of the company's stock, valJune 8 at 3:50 AM | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of "Buy" from AnalystsPacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) has been assigned an average rating of "Buy" from the ten analysts that are currently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average twelve-month target prJune 6, 2024 | marketbeat.comNorges Bank Makes New Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)Norges Bank purchased a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 282,803 shares of the company's stock, valued at apJune 4, 2024 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Sees Unusually-High Trading VolumePacira BioSciences (NASDAQ:PCRX) Sees Unusually-High Trading VolumeJune 3, 2024 | marketbeat.comStephens Investment Management Group LLC Sells 25,659 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Stephens Investment Management Group LLC lessened its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,318,005 shares of the company's stock after selling 25,659June 1, 2024 | americanbankingnews.comQ3 2024 Earnings Forecast for Pacira BioSciences, Inc. Issued By Zacks Research (NASDAQ:PCRX)May 31, 2024 | marketbeat.comZacks Research Comments on Pacira BioSciences, Inc.'s Q3 2024 Earnings (NASDAQ:PCRX)Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) - Research analysts at Zacks Research decreased their Q3 2024 earnings per share (EPS) estimates for Pacira BioSciences in a research report issued on Tuesday, May 28th. Zacks Research analyst R. Department now forecasts that the company will pMay 30, 2024 | globenewswire.comPacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare ConferenceMay 25, 2024 | finance.yahoo.comPacira BioSciences, Inc. (PCRX)May 21, 2024 | marketbeat.comGlobal Alpha Capital Management Ltd. Invests $2.45 Million in Pacira BioSciences, Inc. (NASDAQ:PCRX)Global Alpha Capital Management Ltd. purchased a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7May 19, 2024 | marketbeat.comHillsdale Investment Management Inc. Makes New $4.52 Million Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)Hillsdale Investment Management Inc. purchased a new stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 134,000 sMay 18, 2024 | marketbeat.comFirst Eagle Investment Management LLC Has $3.48 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)First Eagle Investment Management LLC lowered its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 50.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 103,081 shares of the compMay 16, 2024 | marketbeat.comNational Bank of Canada FI Makes New Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)National Bank of Canada FI purchased a new stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 30,200 shares of the company's stock, valued at approximaMay 10, 2024 | markets.businessinsider.comPacira BioSciences Announces Pricing Of $250 Mln Of Convertible Senior Notes, Due 2029May 10, 2024 | finance.yahoo.comEarnings Miss: Pacira BioSciences, Inc. Missed EPS By 17% And Analysts Are Revising Their ForecastsMay 10, 2024 | globenewswire.comPacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029May 8, 2024 | globenewswire.comPacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior NotesMay 8, 2024 | marketbeat.comPacira BioSciences' (PCRX) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $57.00 price target on shares of Pacira BioSciences in a research report on Wednesday.May 8, 2024 | marketbeat.comBarclays Cuts Pacira BioSciences (NASDAQ:PCRX) Price Target to $38.00Barclays reduced their price target on shares of Pacira BioSciences from $40.00 to $38.00 and set an "overweight" rating for the company in a research report on Wednesday.May 8, 2024 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Shares Gap Up to $26.51Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up to $26.51May 8, 2024 | finance.yahoo.comPacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comRussell Investments Group Ltd. Sells 123,756 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Russell Investments Group Ltd. trimmed its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 35.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 226,273 shares of the company's stockMay 8, 2024 | finance.yahoo.comPacira BioSciences Inc (PCRX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ...May 7, 2024 | investorplace.comPCRX Stock Earnings: Pacira BioSciences Meets EPS, Beats Revenue for Q1 2024May 7, 2024 | seekingalpha.comPacira BioSciences, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 7, 2024 | msn.comPacira BioSciences Non-GAAP EPS of $0.62, revenue of $167.11MMay 7, 2024 | finance.yahoo.comPacira BioSciences Reports Q1 2024 Results: Aligns with EPS Projections and Announces $150 ...May 7, 2024 | globenewswire.comPacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase programMay 7, 2024 | finance.yahoo.comPacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare ConferenceMay 1, 2024 | marketbeat.comPacira BioSciences (PCRX) Set to Announce Quarterly Earnings on TuesdayPacira BioSciences (NASDAQ:PCRX) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.April 30, 2024 | globenewswire.comPacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024April 26, 2024 | marketbeat.comWedge Capital Management L L P NC Acquires New Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)Wedge Capital Management L L P NC acquired a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 31,414 shares of the company's stock, valued at apApril 25, 2024 | marketbeat.comabrdn plc Buys 56,081 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)abrdn plc increased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 14.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 448,691 shares of the company's stock after buying an additiApril 22, 2024 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Hits New 12-Month Low at $25.74Pacira BioSciences (NASDAQ:PCRX) Sets New 1-Year Low at $25.74April 17, 2024 | nasdaq.comOversold Conditions For Pacira BioSciences (PCRX)April 16, 2024 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Shares Up 2.7%Pacira BioSciences (NASDAQ:PCRX) Shares Up 2.7%April 15, 2024 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Sets New 52-Week Low at $25.89Pacira BioSciences (NASDAQ:PCRX) Reaches New 12-Month Low at $25.89April 11, 2024 | finance.yahoo.comPacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trendApril 11, 2024 | marketbeat.comBaillie Gifford & Co. Sells 573,810 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Baillie Gifford & Co. trimmed its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 35.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,063,266 shares of the company's stock after selliApril 9, 2024 | markets.businessinsider.comUnderstanding Key Factors Behind Pacira Pharmaceuticals’ Analyst RatingApril 9, 2024 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Given "Buy" Rating at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and issued a $45.00 price target on shares of Pacira BioSciences in a report on Tuesday.April 6, 2024 | nasdaq.comCommit To Purchase Pacira BioSciences At $15, Earn 12.5% Annualized Using OptionsApril 2, 2024 | globenewswire.comPacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 30, 2024 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Assenagon Asset Management S.A.Assenagon Asset Management S.A. raised its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 185.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 246,621 shares of the company's stockMarch 29, 2024 | marketbeat.comGradient Investments LLC Increases Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Gradient Investments LLC raised its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 33.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 139,949 shares of the company's stock afMarch 26, 2024 | marketbeat.comTributary Capital Management LLC Raises Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Tributary Capital Management LLC raised its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 32.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 242,005 shares of the company'sMarch 25, 2024 | marketbeat.comWellington Management Group LLP Lowers Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)Wellington Management Group LLP reduced its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 28.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 313,910 shaMarch 22, 2024 | marketbeat.comDeutsche Bank AG Has $5.60 Million Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Deutsche Bank AG trimmed its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 22.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,399 shares of the company's stock after selling 51,March 18, 2024 | insidertrades.comGary W. Pace Sells 1,066 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution PCRX Media Mentions By Week PCRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼1.100.77▲Average Medical News Sentiment PCRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼63▲PCRX Articles Average Week Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OPKO Health News Today ALX Oncology News Today Atea Pharmaceuticals News Today ADC Therapeutics News Today Seres Therapeutics News Today Perrigo News Today Corcept Therapeutics News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Omeros News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | Sponsored